Seer, Inc. adopted a tax preservation plan to protect its $262 million net operating losses from ownership changes.
Quiver AI Summary
Seer, Inc. announced the adoption of a tax benefit preservation plan to protect its valuable net operating loss (NOL) carryforwards, totaling approximately $262 million as of December 31, 2025. The plan aims to prevent impairment of these NOLs, primarily in light of potential ownership changes that could arise from increased stockholder ownership, thus ensuring they can continue to reduce future federal income tax expenses. The Board declared a dividend of "rights" for each share of Class A common stock, which will be distributed to shareholders on March 9, 2026, and is not taxable. The plan will be submitted for ratification at the annual meeting in 2026 and will expire in 2029 unless ratified sooner. Seer is recognized for its innovative work in proteomics, providing advanced insights through its proprietary technology.
Potential Positives
- The adoption of the NOL Plan aims to preserve approximately $262 million in valuable net operating loss carryforwards, which can significantly reduce future federal income tax expenses for the company.
- The NOL Plan is designed to mitigate the risk of substantial impairment to the NOLs from potential ownership changes, ensuring the long-term financial stability of the company.
- The Board's decision to adopt the NOL Plan reflects proactive governance, demonstrating a commitment to protecting shareholder value and minimizing tax liabilities.
- The issuance of “rights” to shareholders promotes engagement and gives existing shareholders a mechanism to maintain their interests while adhering to the new ownership restrictions stipulated in the NOL Plan.
Potential Negatives
- The adoption of the NOL Plan suggests concern over the potential loss of significant tax assets, which may indicate underlying financial pressures or instability.
- The need to limit shareholder ownership accumulation could signal to the market that the company is defensive about its financial health and governance structure.
- The NOL Plan will expire if not ratified by shareholders, reflecting a dependency on shareholder approval that could create uncertainty or instability in the company’s financial strategy.
FAQ
What is Seer's tax benefit preservation plan?
Seer's NOL Plan aims to preserve its income tax net operating loss carryforwards, protecting them from potential ownership changes.
How much are Seer's net operating loss carryforwards?
As of December 31, 2025, Seer had approximately $262 million in net operating loss carryforwards.
Why is the NOL Plan important for shareholders?
The NOL Plan helps maintain Seer's tax assets, reducing future federal income tax expenses for shareholders.
What happens if shareholders don't ratify the NOL Plan?
If not ratified, the NOL Plan will expire on February 25, 2027, instead of 2029.
Will the distribution of rights be taxable?
No, the distribution of rights to shareholders is not taxable to Seer or its shareholders.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$SEER Insider Trading Activity
$SEER insiders have traded $SEER stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $SEER stock by insiders over the last 6 months:
- OMID FAROKHZAD (CEO AND CHAIR) has made 0 purchases and 2 sales selling 58,223 shares for an estimated $115,353.
- DAVID R. HORN (PRESIDENT & CFO) has made 0 purchases and 2 sales selling 14,540 shares for an estimated $28,846.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$SEER Hedge Fund Activity
We have seen 17 institutional investors add shares of $SEER stock to their portfolio, and 41 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- TANG CAPITAL MANAGEMENT LLC removed 1,344,423 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $2,460,294
- BERKSHIRE ASSET MANAGEMENT LLC/PA removed 275,000 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $503,250
- ROYAL BANK OF CANADA removed 186,319 shares (-72.2%) from their portfolio in Q4 2025, for an estimated $340,963
- D. E. SHAW & CO., INC. removed 182,960 shares (-30.9%) from their portfolio in Q4 2025, for an estimated $334,816
- SHAY CAPITAL LLC removed 143,953 shares (-48.9%) from their portfolio in Q4 2025, for an estimated $263,433
- BRIDGEWAY CAPITAL MANAGEMENT, LLC removed 128,000 shares (-17.4%) from their portfolio in Q4 2025, for an estimated $234,240
- MILLENNIUM MANAGEMENT LLC removed 108,567 shares (-48.2%) from their portfolio in Q4 2025, for an estimated $198,677
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
REDWOOD CITY, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that its Board of Directors unanimously adopted a tax benefit preservation plan (“NOL Plan”) designed to help preserve and protect Seer’s valuable income tax net operating loss carryforwards and other tax assets (“NOLs”).
As of December 31, 2025, Seer had approximately $262 million of NOLs. These NOLs, most of which are not currently subject to any expiration date, represent a valuable asset of Seer and are available to reduce Seer’s future federal income tax expense.
The NOL Plan is similar to those adopted by numerous other public companies with significant NOLs. The NOL Plan helps to reduce the risk of substantial impairment to the NOLs that could result from an “ownership change” within the meaning of Section 382 of the Internal Revenue Code. In general, an “ownership change” would occur if the Company’s “5% stockholders” (within the meaning of Section 382 of the Internal Revenue Code) increase their aggregate ownership in Seer over a rolling three-year period by more than 50 percentage points over their lowest aggregate ownership percentage. The Board of Directors adopted the NOL Plan to help to ensure that the NOLs are not impaired, particularly given recent rapid accumulations of Seer’s Class A common stock.
Seer intends to submit the NOL Plan to its shareholders for ratification at Seer’s 2026 annual meeting. The NOL Plan is not designed to prevent any action that the Board of Directors determines to be in the best interest of Seer and all of its shareholders.
The NOL Plan aims to preserve the NOLs by creating a disincentive for any shareholder to accumulate beneficial ownership of 4.9% or more of Seer’s Class A common stock, or further accumulate Seer’s Class A common stock if the shareholder’s beneficial ownership already exceeds 4.9%, in each case without the approval of the Board of Directors. If a shareholder beneficially owns 4.9% or more of Seer’s Class A common stock prior to today’s announcement, then that shareholder can maintain its current ownership but will not be permitted under the NOL Plan to acquire any additional shares without the approval of the Board of Directors.
In connection with its adoption of the NOL Plan, the Board of Directors declared a dividend of one “right” for each outstanding share of Seer’s Class A common stock. The dividend will be made to shareholders of record as of the close of business on March 9, 2026. Any shares of Seer’s Class A common stock that are issued after the record date will be issued together with a right. The distribution of the rights is not taxable to Seer or its shareholders.
The NOL Plan expires on February 25, 2029. However, if shareholders do not ratify the NOL Plan at Seer’s 2026 annual meeting, the NOL Plan will expire on February 25, 2027.
Additional information about the NOL Plan will be available on a Form 8-K to be filed by Seer with the U.S. Securities and Exchange Commission.
About Seer, Inc.
Seer, Inc. (Nasdaq: SEER) sets the standard in deep, unbiased proteomics, delivering insights with scale, speed, precision, and reproducibility previously unattainable by other proteomic methods. Seer’s Proteograph Product Suite uniquely integrates proprietary engineered nanoparticles, streamlined automation instrumentation, optimized consumables, and advanced analytical software to solve challenges conventional methods have failed to overcome. Traditional proteomic technologies have struggled with inconsistent data, limited throughput, and prohibitive complexity, but Seer’s robust and scalable workflow consistently reveals biological insights that others do not. Seer’s products are for research use only and are not intended for diagnostic procedures. For more information about Seer’s differentiated approach and ongoing leadership in proteomics, visit www.seer.bio .
Forward Looking Statements
This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Such forward-looking statements are based on Seer’s beliefs and assumptions and on information currently available to it on the date of this press release. Forward-looking statements may involve known and unknown risks, uncertainties and other factors that may cause Seer’s actual results, performance, or achievements to be materially different from those expressed or implied by the forward-looking statements. These statements include but are not limited to statements regarding the protection of the NOLs and their value to Seer. These and other risks are described more fully in Seer’s filings with the Securities and Exchange Commission (“SEC”) and other documents that Seer subsequently files with the SEC from time to time. Except to the extent required by law, Seer undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.
Media Contact:
Patrick Schmidt
[email protected]
Investor Contact:
Kelly Gura
[email protected]